Approval · Notice of Compliance 38332 · 2026
INNOHEP: Notice of Compliance 38332
Issued September 22, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38332
- Date
- September 22, 2026
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INNOHEP | Not yet assigned | — |
Medicinal ingredients
- TINZAPARIN SODIUM 20,000 UNIT per ML
- TINZAPARIN SODIUM 10,000 UNIT per ML